This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2003:37:138-62.

doi: 10.1159/000071371.

Cyclooxygenase-2 in lung cancer

Steven M Dubinett¹, Sherven Sharma, Min Huang, Mariam Dohadwala, Mehis Pold, Jenny T Mao

Affiliations

Affiliation

¹ Lung Cancer Research Program, UCLA Jonsson Comprehensive Cancer Center, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, Calif., USA. sdubinett@mednet.ucla.edu

PMID: 12795053
DOI: 10.1159/000071371

Review

Cyclooxygenase-2 in lung cancer

Steven M Dubinett et al. Prog Exp Tumor Res. 2003.

. 2003:37:138-62.

doi: 10.1159/000071371.

Authors

Steven M Dubinett¹, Sherven Sharma, Min Huang, Mariam Dohadwala, Mehis Pold, Jenny T Mao

Affiliation

¹ Lung Cancer Research Program, UCLA Jonsson Comprehensive Cancer Center, Department of Medicine, Geffen School of Medicine at UCLA, Los Angeles, Calif., USA. sdubinett@mednet.ucla.edu

PMID: 12795053
DOI: 10.1159/000071371

No abstract available

PubMed Disclaimer

Similar articles

Multifaceted roles of cyclooxygenase-2 in lung cancer.
Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM. Riedl K, et al. Drug Resist Updat. 2004 Jun;7(3):169-84. doi: 10.1016/j.drup.2004.04.003. Drug Resist Updat. 2004. PMID: 15296859 Review.
Cyclooxygenase-2 in lung carcinogenesis and chemoprevention: Roger S. Mitchell lecture.
Brown JR, DuBois RN. Brown JR, et al. Chest. 2004 May;125(5 Suppl):134S-40S. doi: 10.1378/chest.125.5_suppl.134s-a. Chest. 2004. PMID: 15136465 No abstract available.
Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract.
Altorki NK, Subbaramaiah K, Dannenberg AJ. Altorki NK, et al. Prog Exp Tumor Res. 2003;37:107-23. doi: 10.1159/000071369. Prog Exp Tumor Res. 2003. PMID: 12795051 Review. No abstract available.
Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer.
Gridelli C, Maione P, Airoma G, Rossi A. Gridelli C, et al. Curr Med Chem. 2002 Nov;9(21):1851-8. doi: 10.2174/0929867023368863. Curr Med Chem. 2002. PMID: 12369871 Review.
[Cyclo-oxygenase 2 inhibitors and cancer].
André T, Soria JC. André T, et al. Bull Cancer. 2004 May;91 Spec No:S59-60. Bull Cancer. 2004. PMID: 15239332 French. No abstract available.

See all similar articles

Cited by

Evolving concepts in lung carcinogenesis.
Gomperts BN, Spira A, Massion PP, Walser TC, Wistuba II, Minna JD, Dubinett SM. Gomperts BN, et al. Semin Respir Crit Care Med. 2011 Feb;32(1):32-43. doi: 10.1055/s-0031-1272867. Epub 2011 Apr 15. Semin Respir Crit Care Med. 2011. PMID: 21500122 Free PMC article. Review.
PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.
Baratelli F, Lee JM, Hazra S, Lin Y, Walser TC, Schaue D, Pak PS, Elashoff D, Reckamp K, Zhang L, Fishbein MC, Sharma S, Dubinett SM. Baratelli F, et al. Am J Transl Res. 2010 Jun 30;2(4):356-67. Am J Transl Res. 2010. PMID: 20733946 Free PMC article.
The significance of Notch1 compared with Notch3 in high metastasis and poor overall survival in hepatocellular carcinoma.
Zhou L, Zhang N, Song W, You N, Li Q, Sun W, Zhang Y, Wang D, Dou K. Zhou L, et al. PLoS One. 2013;8(2):e57382. doi: 10.1371/journal.pone.0057382. Epub 2013 Feb 28. PLoS One. 2013. Retraction in: PLoS One. 2024 Apr 2;19(4):e0301556. doi: 10.1371/journal.pone.0301556. PMID: 23468978 Free PMC article. Retracted.
Specific Biomarkers Are Associated with Docetaxeland Gemcitabine-Resistant NSCLC Cell Lines.
Pasini A, Paganelli G, Tesei A, Zoli W, Giordano E, Calistri D. Pasini A, et al. Transl Oncol. 2012 Dec;5(6):461-8. doi: 10.1593/tlo.12256. Epub 2012 Dec 1. Transl Oncol. 2012. PMID: 23397475 Free PMC article.
Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.
Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM. Lee JM, et al. Crit Rev Oncol Hematol. 2008 Jun;66(3):208-17. doi: 10.1016/j.critrevonc.2008.01.004. Epub 2008 Mar 4. Crit Rev Oncol Hematol. 2008. PMID: 18304833 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

P50 CA90388/CA/NCI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program